Michael M. Allevato
-
- Cancer Immunotherapy and Biomarkers 5
- Peptidase Inhibition and Analysis 4
- Lung Cancer Research Studies 3
-
- Cancer, Hypoxia, and Metabolism 2
-
- Immunotherapy and Immune Responses 3
-
- Ubiquitin and proteasome pathways 2
-
- Salivary Gland Tumors Diagnosis and Treatment 2
-
- Advanced Breast Cancer Therapies 1
- Co-authors
- J. Silvio GutkindAlfredo MolinoloZhiyong WangEzra E.W. CohenMara GilardiVictoria H. WuYusuke GotoBryan S. Yung
- Journals
- Nature Communications (3 papers)Genes & Development (1 paper)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- United StatesThailandChina
In The Last Decade
Michael M. Allevato
13 papers receiving 334 citations
Peers
Comparison fields: 5 of 59
- Oncology 145
- Otorhinolaryngology 19
- Cancer Research 61
- Immunology 79
- Molecular Biology 178
Countries citing papers authored by Michael M. Allevato
This map shows the geographic impact of Michael M. Allevato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael M. Allevato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael M. Allevato more than expected).
Fields of papers citing papers by Michael M. Allevato
This network shows the impact of papers produced by Michael M. Allevato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael M. Allevato. The network helps show where Michael M. Allevato may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael M. Allevato, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 8 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 10 | |
| 9 | 2023 | 4 | |
| 10 | 2022 | 39 | |
| 11 | 2021 | 51 | |
| 12 | 2021 | 2 | |
| 13 | 2019 | 54 | |
| 14 | 2019 | 119 | |
| 15 | 2017 | 38 |
About Michael M. Allevato
Michael M. Allevato is a scholar working on Oncology, Cancer Research and Immunology, having authored 15 papers that have together received 336 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Peptidase Inhibition and Analysis (4 papers), Lung Cancer Research Studies (3 papers), Immunotherapy and Immune Responses (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Ubiquitin and proteasome pathways (2 papers), Salivary Gland Tumors Diagnosis and Treatment (2 papers) and Advanced Breast Cancer Therapies (1 paper). The work is most often cited by research in Oncology (145 citations), Otorhinolaryngology (19 citations) and Cancer Research (61 citations). Michael M. Allevato has collaborated with scholars based in United States, Thailand and China. Frequent co-authors include J. Silvio Gutkind, Alfredo Molinolo, Zhiyong Wang, Ezra E.W. Cohen, Mara Gilardi, Victoria H. Wu, Yusuke Goto, Bryan S. Yung, Lynn Vitale‐Cross and Andrew B. Sharabi. Their work appears in journals such as Nature Communications, Genes & Development and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.